Sarah Cannon Research Institute
Debra Meyer possesses extensive experience in clinical research and administrative support within the healthcare sector. Currently serving as a Clinical Research Associate at Sarah Cannon Research Institute since September 2010, Debra advanced from Data Coordinator to Clinical Trials Manager I, where responsibilities include leading trial executions, managing data collection, ensuring patient eligibility, and assisting with regulatory audits. Prior to this role, Debra was an Administrative Assistant at Vanderbilt University Medical Center, where duties involved scheduling for multiple healthcare providers, managing patient communications, processing documentation, and maintaining operational efficiency within the clinic.
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.